Eunkyung Jung’Review of introduction of vaccine in Russia… Vaccine uncertainty response dimension’

Eunkyung Jung’Review of introduction of vaccine in Russia… Vaccine uncertainty response dimension’

by

Commissioner Jeong “AstraZeneca, we should see the results of clinical trials”

viewer

Citizens Participation Special Feature, where Jung Eun-kyung, head of the central quarantine countermeasures head of the Corona 19 vaccination response promotion group (Corporation Administration), asks and answers questions related to the new coronavirus infection (Corona 19) vaccination held at the Centers for Disease Control and Prevention in Cheongju, Chungcheongbuk-do. Answering civic questions at briefing / Yonhap News

On the 8th, the Korea Centers for Disease Control and Prevention (KCDC) chief said, “We will consider introducing the Russian’Sputnik V’vaccine” in response to uncertainties about the novel coronavirus infection (Corona 19) vaccine.

In the’Citizen Participation Special Briefing’ of the Agency for Disease Control and Prevention Vaccination Promotion Group, Commissioner Chung said, “In relation to the Russian Sputnik vaccine, there is such uncertainty as a variant virus or supply issue, so we will continue to review the necessity of obtaining additional vaccines.” Said this. “We are continuing to review the contract for NovaVax vaccine,” Chung said. “If the contract between NovaVax and SK Bioscience is signed, we are also considering signing a contract with SK Bioscience.”

In relation to the AstraZeneca vaccine, which is continuing controversy over the’vaccination effect’ due to insufficient clinical trial participants, Chung said, “We are looking at the results of additional clinical trials.” It is supposed to be done, so I think I have to see the contents of the license and the results of the clinical trial.

/ Intern reporter Hyein Lee [email protected]

< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >

Source